Philippe Camus, M.D.

Dijon, France

Back

The Drug-Induced Respiratory Disease Website

XXIV.i

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

Progression, acceleration or exacerbation of preexisting ILD/fibrosis

Last update 17/06/2026

(Fr: aggravation d'une Pn interstitielle préexistante). The preexistinf ILD can be idiopathic pulmonary fibrosis (IPF), rheumatoid lung, CTD-related or any kind of ILD/pulmonary fibrosis. Can cause acute fatal respiratory failure in 25-30% of those affected. See also Iw.

Causative drugs

10
Anticoagulants, oral (vitamin K antagonists-VKA)
XII.c
XIV.e
XVI.a
XVI.b
XVI.c
XVI.d
XVI.e
XVI.i
XVI.k
XVI.l
XVI.m
XVI.n
XVI.o
XXIV.i
XXVIII.a
XXVIII.i
XXXII.a
XXXVII.e
XXXVIII.l
Coronavirus (SARS-COVID19) vaccination/vaccine
I.a
I.l
II.a
III.a
V.a
V.b
V.f
V.h
VI.c
X.a
XI.a
XI.j
XII.a
XII.b
XII.e
XIII.a
XV.a
XVI.e
XVI.h
XX.c
XX.d
XXII.b
XXIV.a
XXIV.b
XXIV.c
XXIV.i
XXIV.v
XXIX.a
XXIX.h
XXX.l
XXX.p
XXX.s
XXXVI.b
XXXVI.f
XXXVI.i
XXXVI.j
XXXVI.n
XXXVI.x
XXXVI.z
XXXVI.ae
XXXVIII.c
XXXVIII.q
Dasatinib
X.d
XI.a
XII.b
XII.g
XII.n
XIV.a
XIV.h
XIV.n
XV.a
XV.e
XXIV.a
XXIV.i
XXIV.j
XXIV.ad
XXX.w
XXX.x
XXXVI.b
Denosumab
XX.d
XXIV.a
XXIV.i
XXIV.k
XXVII.a
XXVIII.a
XXXVIII.u
XXXVIII.v
Immune checkpoint inhibitors (ICI) - ICI combinatorial Rx
I.a
I.m
II.a
II.c
II.d
III.a
IV.a
V.a
V.e
VI.c
VII.a
X.a
XI.a
XII.b
XIII.a
XIV.a
XIV.i
XV.e
XVI.h
XXI.a
XXII.b
XXIV.a
XXIV.b
XXIV.c
XXIV.d
XXIV.e
XXIV.h
XXIV.i
XXIV.j
XXIV.l
XXIV.o
XXIV.q
XXIV.v
XXIV.ab
XXIV.ac
XXIX.a
XXIX.i
XXX.h
XXXIII.f
XXXVI.f
XXXVI.q
XXXVI.v
Infliximab
V.a
XII.a
XII.g
XIII.a
XIII.n
XIV.a
XVI.e
XXII.b
XXIV.a
XXIV.b
XXIV.c
XXIV.d
XXIV.h
XXIV.i
XXIV.j
XXIV.o
XXIX.a
XXX.l
XXXVI.a
XXXVI.b
XXXVI.u
XXXVIII.c
Nintedanib
XI.a
XXIV.i
Surgical lung biopsy
XXIV.i
Tocilizumab
XII.b
XXIV.a
XXIV.i
XXIV.j
XXVIII.d
XXXIV.f
XXXVI.c
Waterproofing agents/sprays - Household cleansing agents and aerosols
XVI.e
XXII.b
XXIII.a
XXIV.a
XXIV.b
XXIV.d
XXIV.i
XXXVIII.d